# Electrochemotherapy for Recurrent Vulvar Cancer

Source: https://onco.cc/trials/nct07443475/  
OnCo record `nct07443475` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Electrochemotherapy in Vulvar cancer, run by Institute of Oncology Ljubljana, now recruiting.

## Summary

Electrochemotherapy for Recurrent Vulvar Cancer is a phase 2 interventional study registered as NCT07443475 by Institute of Oncology Ljubljana, with 13 participants planned, started 2021-09-01 and due to reach its primary completion in 2026-08-31. Interventions recorded: Electrochemotherapy (ECT). Conditions recorded: Vulvar Cancer, Recurrent Vulvar Cancer.

Linked to the technology Electrochemotherapy because the registry names it ("electrochemotherapy") among its interventions and Vulvar cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07443475
- Phase: 2
- Setting: Use of Electrochemotherapy in Women With Vulvar Cancer
- Sponsor: Institute of Oncology Ljubljana
- Enrolled: 13

## Sources

- ClinicalTrials.gov NCT07443475: https://clinicaltrials.gov/study/NCT07443475

## Connected records

- cancers: [Vulvar cancer](https://onco.cc/cancers/vulvar/)
- technologies: [Electrochemotherapy](https://onco.cc/technologies/electrochemotherapy/)

---
JSON: https://onco.cc/api/v1/entities/nct07443475.json